Quick Answer
Climb Bio, Inc. reported Shares Outstanding of 47.77 million shares for fiscal year 2025.
Climb Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 47.77M | -29.0% |
| 2024 | 67.26M | +142.8% |
| 2023 | 27.70M | +4.3% |
| 2022 | 26.57M | +0.0% |
| 2021 | 26.57M | +677.1% |
| 2020 | 3.42M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 68.18M | +1.4% | +0.6% |
| June 30, 2025 | 67.76M | +1.5% | +0.3% |
| March 31, 2025 | 67.58M | +143.7% | +0.5% |
| December 31, 2024 | 67.26M | +142.8% | +0.0% |
| September 30, 2024 | 67.22M | +144.8% | +0.7% |
| June 30, 2024 | 66.79M | +147.4% | +140.9% |
| March 31, 2024 | 27.72M | +2.8% | +0.1% |
| December 31, 2023 | 27.70M | +4.3% | +0.8% |
- Climb Bio, Inc. showed a decrease of -29.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Climb Bio, Inc.’s shares outstanding has grown by 1297.2% (from 3.42 million shares to 47.77 million shares).
- The most recent figure is from Climb Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: